| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Moleculin Biotech, Inc. (MBRX) have been net buyers, picking up 2,399,997 shares on balance.
Classified under Biotechnology (Health Care sector), MBRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.55M | - | - | |
| CFO | 1.42M | - | - | |
| Other | 789.6K | - | - | |
| Dir | 165.3K | - | - | |
| Dir | 165.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Klemp Walter V | CEO And President | Buy | 109,955 | $0.98 | $107,870.64 | +47.3% | +25.0% | -43.3% | |
| Aug 16, 2017 | Priebe Waldemar74 | 10% Owner | Sell | 100,000 | $1.70 | $170,300.00 | -3.5% | - | - | |
| Aug 16, 2017 | Klemp Walter V | Chief Executive Officer | Sell | 100,000 | $1.70 | $170,300.00 | -9.4% | - | - | |
| May 11, 2017 | Klemp Walter V | Chief Executive Officer | Buy | 12,000 | $0.81 | $9,720.00 | +1.1% | - | - | |
| May 5, 2017 | Northcut Jacqueline | Director | Buy | 1,000 | $0.82 | $820.00 | New | - | - | |
| Apr 28, 2017 | George Robert E. | Director | Buy | 1,000 | $0.94 | $938.40 | New | - | - | |
| Apr 25, 2017 | Foster Jonathan P. | Exec. Vice President &CFO | Buy | 10,000 | $0.86 | $8,649.00 | New | - | - |